Leon Nanodrugs Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
Series D
- Investors
-
11
Leon Nanodrugs General Information
Description
Developer of drugs through nanoscience designed to offer patient outcomes. The company's drugs specialize in improving the bioavailability of poorly water-soluble medicine by using their proprietary technology to create either polymeric or crystalline nanoparticles, enabling medical professionals to get nano-formulated drugs with meaningful differentiation and added benefits.
Contact Information
Website
www.leon-nanodrugs.comCorporate Office
- Am Klopferspitz 19
- 82152 Planegg
- Germany
Corporate Office
- Am Klopferspitz 19
- 82152 Planegg
- Germany
Leon Nanodrugs Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series D) | 06-Aug-2024 | 000.00 | Completed | Generating Revenue | ||
| 4. Later Stage VC (Series C) | 000.00 | Completed | Generating Revenue | |||
| 3. Secondary Transaction - Private | 01-Jul-2020 | 000.00 | Completed | Generating Revenue | ||
| 2. Later Stage VC (Series B) | 16-Apr-2020 | $20.5M | Completed | Generating Revenue | ||
| 1. Later Stage VC (Series A) | 27-Jul-2015 | $20.5M | $20.5M | 0000 | Completed | Generating Revenue |
Leon Nanodrugs Comparisons
Industry
Financing
Details
000000
000000
Leon Nanodrugs Competitors (18)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Genkyotex | Corporate Backed or Acquired | Saint-Julien- en-Genevois, France | 00 | 000.00 | 000000&0 | 000.00 |
| BioVersys | Venture Capital-Backed | Basel, Switzerland | 00 | 00000 | 00000 00000 | |
| Precision Nanosystems | Formerly VC-backed | Vancouver, Canada | 000 | 000.00 | 000000&0 | 000.00 |
| Cytovance Biologics | Formerly PE-Backed | Oklahoma City, OK | 000 | 0000 | 000000&0 | 0000 |
| NanoMedical Systems | Venture Capital-Backed | Austin, TX | 0 | 000.00 | 00000000000 | 000.00 |
Leon Nanodrugs Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Leon Nanodrugs Patents
Leon Nanodrugs Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4247529-A1 | Apparatus and method for mixing small liquid volumes, and use of the apparatus | Pending | 03-Nov-2021 | 000000000 | |
| CA-3237294-A1 | Apparatus and method for mixing small liquid volumes, and use of the apparatus | Pending | 03-Nov-2021 | 000000000 | |
| AU-2022381525-A1 | Apparatus and method for mixing small liquid volumes, and use of the apparatus | Pending | 03-Nov-2021 | 000000000 | |
| EP-4162930-A1 | Preparation of drug-loaded micro- and nanoparticles by jet impingement | Pending | 11-Oct-2021 | 0000000000 | 0 |
| US-11744805-B2 | Methods for validating an apparatus for producing nanoparticles | Active | 11-Oct-2021 | A61K9/5192 | 00 |
Leon Nanodrugs Executive Team (11)
| Name | Title | Board Seat |
|---|---|---|
| Hans Frickel | Chief Executive Officer | |
| Christian Nafe | Chief Financial Officer & Managing Director | |
| Wolfgang Beier | Co-Founder & Chief Scientific Officer | |
| Setu Kasera | Chief Scientific Officer | |
| Anne Burger | Director of Finance |
Leon Nanodrugs Board Members (13)
| Name | Representing | Role | Since |
|---|---|---|---|
| Enno Spillner | Evotec | Supervisory Board Member | 000 0000 |
| Frank Mathias Ph.D | Self | Supervisory Board Member | 000 0000 |
| Frank Muhlenbeck | Self | Supervisory Board Member | 000 0000 |
| Gerhard Ries Ph.D | LifeCare Partners | Supervisory Board Member | 000 0000 |
| Hubert Birner Ph.D | TVM Capital Life Science | Chairman | 000 0000 |
Leon Nanodrugs Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Leon Nanodrugs Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| LBBW Venture Capital | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |
| Albany Capital (Australia) | Venture Capital | Minority | 000 0000 | 000000 0 |
| BayBG Venture Capital | Venture Capital | Minority | 000 0000 | 000000 0 |
| Eckenstein-Geigy-Stiftung | Not-For-Profit Venture Capital | Minority | 000 0000 | 000000 0 |
| Evotec | Corporation | Minority | 000 0000 | 000000 0 |
Leon Nanodrugs FAQs
-
When was Leon Nanodrugs founded?
Leon Nanodrugs was founded in 2010.
-
Who is the founder of Leon Nanodrugs?
Wolfgang Beier and Cornelia Beier are the founders of Leon Nanodrugs.
-
Who is the CEO of Leon Nanodrugs?
Hans Frickel is the CEO of Leon Nanodrugs.
-
Where is Leon Nanodrugs headquartered?
Leon Nanodrugs is headquartered in Planegg, Germany.
-
What is the size of Leon Nanodrugs?
Leon Nanodrugs has 12 total employees.
-
What industry is Leon Nanodrugs in?
Leon Nanodrugs’s primary industry is Drug Discovery.
-
Is Leon Nanodrugs a private or public company?
Leon Nanodrugs is a Private company.
-
What is Leon Nanodrugs’s current revenue?
The current revenue for Leon Nanodrugs is 000000.
-
How much funding has Leon Nanodrugs raised over time?
Leon Nanodrugs has raised $20.5M.
-
Who are Leon Nanodrugs’s investors?
LBBW Venture Capital, Albany Capital (Australia), BayBG Venture Capital, Eckenstein-Geigy-Stiftung, and Evotec are 5 of 11 investors who have invested in Leon Nanodrugs.
-
Who are Leon Nanodrugs’s competitors?
Genkyotex, BioVersys, Precision Nanosystems, Cytovance Biologics, and NanoMedical Systems are some of the 18 competitors of Leon Nanodrugs.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
